Table 1.
Baseline characteristics of PPC and non-PPC patients
| Total (n = 285) |
PPC (n = 21) |
Non-PPC (n = 264) |
p value | ||
|---|---|---|---|---|---|
| Gender (male) | 137 (48.1%) | 13 (61.9%) | 124 (47%) | 0.28 | |
| Age (years) median, IQR | 69.0 (13) | 70.0 (10) | 69.0 (13) | 0.84 | |
| FEV1% predicted mean (±SD) | 87.0 (±19) | 88.8 (±21.6) | 87.5 (±19.8) | 0.78 | |
| ASA score ≥ 3 | 144 (50.5%) | 14 (66.7%) | 130 (49.2%) | 0.19 | |
| Preoperative activity level ≤ 400 m | 84 (29.5%) | 7 (8.4%) | 77 (91.6%) | 0.88 | |
| BMI ≥30 | 63 (22.1%) | 4 (19%) | 59 (22.3%) | 0.49 | |
| COPD | 84 (29.5%) | 11 (52.4%) | 73 (27.7%) | 0.03 | |
| Current smoker | 60 (21.1%) | 9 (42.9%) | 51 (19.3%) | 0.02 | |
| NSCLC Staging | IA | 118 (45.7%) | 9 (52.9%) | 109 (45.2%) | 0.54 |
| IB | 83 (32.2%) | 4 (23.5%) | 79 (32.8%) | ||
| IIA | 40 (15.5%) | 2 (11.8%) | 38 (15.8%) | ||
| IIB | 5 (1.9%) | 0 (0%) | 5 (2.1%) | ||
| IIIA | 12 (4.7%) | 2 (11.8%) | 10 (4.1%) | ||
| Secondary metastatic disease | 27 (9.5%) | 4 (14.8%) | 23 (85.2%) | 0.12 | |
| Analgesia | Paravertebral | 233 (81.8%) | 18 (85.7%) | 215 (81.4%) | 0.19 |
| Epidural | 27 (9.5%) | 0 (0%) | 27 (10.2%) | ||
| PCA / othera | 25 (8.8%) | 3 (14.3%) | 22 (8.3%) | ||
PPC, postoperative pulmonary complication; ASA, American Society of Anaethesiologists; BMI, body mass index; COPD, chronic obstructive pulmonary disease; PCA, patient controlled analgesia; amorphine infusion (n = 3)